கியூபா ஃபின்லே நிறுவனம் ஆஃப் தடுப்பு மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கியூபா ஃபின்லே நிறுவனம் ஆஃப் தடுப்பு மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கியூபா ஃபின்லே நிறுவனம் ஆஃப் தடுப்பு மருந்துகள் Today - Breaking & Trending Today

Cuba expects high efficacy of dosmestic COVID-19 vaccines


Cuba expects high efficacy of dosmestic COVID-19 vaccines
Xinhua |
Updated: 2021-06-03 14:56
HAVANA - Cuba expects its domestic COVID-19 vaccines show high efficacy after the final stage of clinical trials, the country s biopharmaceutical authorities told a press conference Wednesday.
Our locally produced coronavirus vaccines have demonstrated safety and effectiveness, said Eduardo Martinez, president of the state-owned company BioCubaFarma.
We aspire that our vaccines surpass 50 percent of efficacy in keeping with the World Health Organization s standards, he added.
Vicente Verez, director general of Cuba s Finlay Institute of Vaccines, said that a clinical trial was expected to begin in the coming weeks to test the efficacy of domestic COVID-19 vaccine candidates in children. ....

Ciudad De La Habana , Eduardo Martinez , Vicente Verez , World Health Organization , Cuba Finlay Institute Of Vaccines , Finlay Institute , யடட டி லா ஹபனா , எட்வார்டொ மார்டினெஸ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , கியூபா ஃபின்லே நிறுவனம் ஆஃப் தடுப்பு மருந்துகள் , ஃபின்லே நிறுவனம் ,

Cuba's Soberana 02 COVID-19 vaccine starts phase 3 trials - World News


2021-03-05 05:05:39 GMT2021-03-05 13:05:39(Beijing Time) Xinhua English
HAVANA, March 4 (Xinhua) Cuba on Thursday started phase 3 clinical trials of its Soberana 02 COVID-19 vaccine, Vicente Verez, director general of Cuba s Finlay Institute of Vaccines, told a press conference.
We are entering a crucial phase to demonstrate the efficacy of the vaccine, he said. Results from preclinical studies are public and being submitted to important scientific magazines.
After being approved by the Center for State Control of Drugs and Medical Devices on Wednesday, the domestically produced vaccine candidate is due to begin the inoculation of volunteers later in March.
The study plans to enroll more than 44,000 participants aged 19-80 from Havana, the epicenter of the COVID-19 pandemic on the island. ....

Ciudad De La Habana , Vicente Verez , Cuba National Center , Cuba Finlay Institute Of Vaccines , Finlay Institute , State Control , Medical Devices , National Center , யடட டி லா ஹபனா , கியூபா தேசிய மையம் , கியூபா ஃபின்லே நிறுவனம் ஆஃப் தடுப்பு மருந்துகள் , ஃபின்லே நிறுவனம் , நிலை கட்டுப்பாடு , மருத்துவ சாதனங்கள் , தேசிய மையம் ,

Live COVID-19 updates: Cuba's Soberana 02 COVID-19 vaccine starts phase 3 trials


news
Live COVID-19 updates: Cuba s Soberana 02 COVID-19 vaccine starts phase 3 trials
Kong Weiyi
© Provided by N.C.N. Limited
People wearing face masks walk on the street in Havana, Cuba, July 4, 2020. (Xinhua/Zhu Wanjun)
- Cuba s Soberana 02 COVID-19 vaccine starts phase 3 trials
- Brazil s daily COVID-19 death toll tops 1,600 for 3 consecutive days
- Africa s confirmed COVID-19 cases near 3.93 mln
BEIJING, March 5 (Xinhua) The following are the updates on the global fight against the COVID-19 pandemic.
- - - -
HAVANA Cuba on Thursday started phase 3 clinical trials of its Soberana 02 COVID-19 vaccine, Vicente Verez, director general of Cuba s Finlay Institute of Vaccines, told a press conference. ....

Sao Paulo , Koh Kong , Phnom Penh , New Zealand General , New Zealand , Estado De Pernambuco , Addis Ababa , Ciudad De La Habana , Xinhua Zhu Wanjun , Xinhua Michael Tewelde , Vicente Verez , Patrasso Xinhua , National Health Commission , Ministry Of Health , Africa Centers For Disease , Cuba Finlay Institute Of Vaccines , Health Ministry , African Union , Ministry Of Health Mo , Zhu Wanjun , Finlay Institute , Preah Sihanouk , Metropolitan Region , Health Minister Enrique Paris , Michael Tewelde , Africa Centers ,

South African union asks to consider Cuba's Covid-19 vaccine


South African union asks to consider Cuba s Covid-19 vaccine
South African union asks to consider Cuba s Covid-19 vaccine
Pretoria, Feb 9 (Prensa Latina) The National Education, Health and Allied Workers Union (NEHAWU) in South Africa advocated for assessing the use in the country of Covid-19 vaccine candidates developed in Cuba and Russia.
The request to the government comes after some scientific studies suggested that the AstraZeneca vaccine bought by South Africa has poorer efficacy against Covid-19 in its mild and moderate forms, caused by the 501Y.V2 viral variant emerged in the country.
In a statement, NEHAWU affirms that the government should consider (the use of) the two coronavirus vaccine candidates, Soberana 1 and Soberana 2, developed by Cuba s Finlay Institute of Vaccines. ....

South Africa , South African , South Africans , Temas Relacionados , Moscow Gamalei Research Center , National Education , Cuba Finlay Institute Of Vaccines , Worker Union , Prensa Latina , Allied Worker Union , Finlay Institute , Gamalei Research Center , Lancet Journal , Covid 19 , தேசிய கல்வி , கியூபா ஃபின்லே நிறுவனம் ஆஃப் தடுப்பு மருந்துகள் , தொழிலாளி தொழிற்சங்கம் , ப்ரெந்ஸ லத்தீன் , கூட்டணி தொழிலாளி தொழிற்சங்கம் , ஃபின்லே நிறுவனம் ,